Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|September 15, 2021
The nose is the best niche for detection of experimental pneumococcal colonisation in adults of all ages, using nasal washElissavet Nikolaou, Esther L German, Annie Blizard, et al.
Mucosal Immunology|July 1, 2024
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adultsBritta C Urban, André N A Gonçalves, Dessi Loukov, et al.
Vaccine|February 10, 2020
Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynxCaz Hales, Simon P Jochems, Rachel Robinson, et al.
BMJ Open|November 25, 2025
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate Streptococcus pneumoniae serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15)Bruno Rocha de Macedo, Carla Solórzano, Angela Hyder-Wright, et al.
Nature Communications|October 26, 2023
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationElena Mitsi, Mariana O Diniz, Jesús Reiné, et al.
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Emerging Infectious Diseases|September 12, 2020
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 DiagnosisRachel L Byrne, Grant A Kay, Konstantina Kontogianni, et al.
Pageof 5